浙江交科(002061.SZ):部分化工生產裝置年度例行停車檢修
格隆匯 1 月 3日丨浙江交科(002061.SZ)公佈,為確保化工生產裝置的安全、平穩運行,浙江交通科技股份有限公司全資子公司寧波浙鐵江寧化工有限公司、寧波浙鐵大風化工有限公司於2020年12月29日起,陸續對順酐、聚碳酸酯(PC)及相關生產裝置(即寧波生產基地)展開年度例行停車檢修工作,上述裝置計劃於2021月1月底前恢復生產。此次檢修是根據年度生產計劃安排的例行裝置檢修。
此次檢修將減少部分產品當月產量,但不影響公司年度生產計劃的完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.